Login / Signup

Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-Raf.

Connor M BlairNicola M WalshBruce H LittmanFrank W MarcouxGeorge S Baillie
Published in: BMC cancer (2019)
Our data suggests that the PDE8A-C-Raf complex is a promising therapeutic treatment for B-Raf inhibitor resistant melanoma.
Keyphrases
  • single cell
  • electronic health record
  • skin cancer
  • cell therapy
  • cancer therapy
  • big data
  • stem cells
  • machine learning
  • mesenchymal stem cells
  • drug delivery
  • basal cell carcinoma